Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;55(12):5761-9.
doi: 10.1128/AAC.05391-11. Epub 2011 Oct 3.

PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients

Affiliations

PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients

Amanda K Miller et al. Antimicrob Agents Chemother. 2011 Dec.

Abstract

Pseudomonas aeruginosa can develop resistance to polymyxin and other cationic antimicrobial peptides. Previous work has shown that mutations in the PmrAB and PhoPQ regulatory systems can confer low to moderate levels of polymyxin resistance (MICs of 8 to 64 mg/liter) in laboratory and clinical strains of this organism. To explore the role of PhoPQ in high-level clinical polymyxin resistance, P. aeruginosa strains with colistin MICs > 512 mg/liter that had been isolated from cystic fibrosis patients treated with inhaled colistin (polymyxin E) were analyzed. Probable loss-of-function phoQ alleles found in these cystic fibrosis strains conferred resistance to polymyxin. Partial and complete suppressor mutations in phoP were identified in some cystic fibrosis strains with resistance-conferring phoQ mutations, suggesting that additional loci can be involved in polymyxin resistance in P. aeruginosa. Disruption of chromosomal phoQ in the presence of an intact phoP allele stimulated 4-amino-l-arabinose addition to lipid A and induced transcription from the promoter of the pmrH (arnB) operon, consistent with the known role of this lipid A modification in polymyxin resistance. These results indicate that phoQ loss-of-function mutations can contribute to high-level polymyxin resistance in clinical strains of P. aeruginosa.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Effect of phoPQ mutations on P. aeruginosa Pm resistance. (A) PMB quantitative bactericidal assay of strains 1995 (PAK ΔpmrAB phoQ6) and 2248 (PAK ΔpmrAB ΔphoPQ). (B) Alternative PMB plate assay of the PAK ΔphoPQ strain expressing the phoPQ+, phoPQ6, or phoP+ allele inserted in plasmid pJN105D. (C) Alternative PMB plate assay of chromosomal deletion mutants PAK ΔphoQ and PAK ΔpmrAB ΔphoQ as well as PAK ΔphoQ expressing the phoPQ+ alleles inserted in plasmid pJN105D. (D) Alternative PMB plate assay of the PAK ΔphoPQ strain expressing mutant phoPQ alleles from CF clinical isolates in plasmid pJN105D. The phoP+Q21 and phoP+Q24 alleles encode deletions from PhoQ of 2 and 276 amino acids, respectively, while the phoP24Q24 allele also encodes replacement in PhoP of Arg 118 with Cys.
Fig. 2.
Fig. 2.
Lipid A structures of Pms and Pmr strains. (A) Diagram of lipid A structural modifications found in P. aeruginosa. (B to D) MALDI-TOF mass spectra for (B) PAK ΔpmrAB (strain 1812), (C) PAK ΔpmrAB phoQ6 (strain 1995), and (D) PAK ΔpmrAB ΔphoPQ (strain 2244).
Fig. 3.
Fig. 3.
Transcriptional activity of phoPQ+, phoPQ6, phoP+, phoP+Q21, phoP23Q23, phoP23, phoP24Q24, phoP24, and phoP+Q24 alleles expressed from pJN105D in reporter strain PAO1 ΔphoPQ Ω[attP::Φ(PpmrH-lacZ+)]. Data shown represent the means of the results of triplicate biological experiments; error bars represent ± standard deviations. Fold induction values shown were calculated relative to the values determined for the WT phoPQ+ allele.

References

    1. Aaron S. D., et al. 2010. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 304: 2145–2153 - PubMed
    1. Adams M. D., et al. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53: 3628–3634 - PMC - PubMed
    1. Al-Aloul M., et al. 2004. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 59: 334–336 - PMC - PubMed
    1. Alonso A., Campanario E., Martinez J. L. 1999. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145(Pt. 10): 2857–2862 - PubMed
    1. Armstrong D. S., et al. 2002. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am. J. Respir. Crit. Care Med. 166: 983–987 - PubMed

Publication types

MeSH terms